Biogen Inc. (BIIB) vs Medline Inc. (MDLN)
A side-by-side comparison of Biogen Inc. and Medline Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
BIIB
Biogen Inc.
$217.15HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
MDLN
Medline Inc.
$32.53HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — BIIB vs MDLN
growth of $100 · dividends reinvested · last 1yBIIB +21.3% (+21.3%/yr)MDLN -21.0% (-21.0%/yr)BIIB compounded faster over this window
BIIB MDLN
BIIB vs MDLN: by the numbers
- •BIIB is the larger company ($32.08B vs $27.51B market cap).
- •MDLN trades at the lower trailing earnings multiple (37.83 vs 38.43 P/E), one valuation lens rather than an overall verdict.
- •BIIB converts more revenue to profit (8.39% vs 2.31% net margin).
Metrics side by side
Valuation
| Metric | BIIB | MDLN |
|---|---|---|
| P/E ratio | 38.43 | 37.83 |
| Forward P/E | 17.39 | 21.79 |
| P/S ratio | 3.23 | 0.92 |
| P/B ratio | 1.70 | 2.38 |
| EV / EBITDA | N/A | 13.73 |
| FCF yield | 8.40% | 4.88% |
Profitability
| Metric | BIIB | MDLN |
|---|---|---|
| Gross margin | 67.71% | 25.02% |
| Operating margin | 12.79% | 6.07% |
| Net margin | 8.39% | 2.31% |
| ROE | 4.43% | 5.97% |
| ROIC | 4.28% | 4.05% |
Growth (annualized)
| Metric | BIIB | MDLN |
|---|---|---|
| Revenue CAGR (5Y) | -3.19% | N/A |
| EPS CAGR (5Y) | -18.67% | N/A |
| FCF CAGR (5Y) | -11.63% | N/A |
| Total return CAGR (5Y) | -6.40% | N/A |
Frequently asked
- Which has the lower trailing P/E, BIIB or MDLN?
- MDLN has the lower trailing P/E: BIIB trades at 38.43 and MDLN at 37.83. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Is BIIB or MDLN more profitable?
- BIIB runs the higher net margin — BIIB at 8.39% versus MDLN at 2.31%.
Go deeper
Dig into the metrics
Biogen P/E ratioMedline P/E ratioBiogen ROEMedline ROEBiogen operating marginMedline operating marginBiogen revenue growthMedline revenue growthBiogen free cash flowMedline free cash flow
Biogen & Medline appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.